MedDataX Logo

McGRATH vs Macintosh Laryngoscopy Comparison in LMA Insertion

NCT ID: NCT04509453

Last Updated: 2020-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

102 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-08-30

Study Completion Date

2020-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Various techniques have been developed to get a good LMA position, one of them is using a laryngoscope. The most popular laryngoscope used for LMA installation is the Macintosh type. Technological developments have brought laryngoscopes into the video era, one of which is McGRATH's laryngoscope, which from several studies about having an advantage in terms of the first attempt, time, complications, and hemodynamic stability of intubation. It needs to be proven through research on the comparison of clinical outcomes of LMA installation with McGrath laryngoscope and Macintosh laryngoscope.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intubation Complication Intubation;Difficult Anesthesia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

successful intubation classic LMA video laryngoscopy difficulty cuff pressure leak

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

McGRATH

Group Type EXPERIMENTAL

McGRATH laryngoscopy

Intervention Type DEVICE

Patients who underwent general anesthesia with LMA insertion by using McGRATH video layngoscopy

Macintosh laryngoscopy

Intervention Type DEVICE

Patients who underwent general anesthesia with LMA insertion by using classic Macintosh video layngoscopy

Macintosh

Group Type ACTIVE_COMPARATOR

McGRATH laryngoscopy

Intervention Type DEVICE

Patients who underwent general anesthesia with LMA insertion by using McGRATH video layngoscopy

Macintosh laryngoscopy

Intervention Type DEVICE

Patients who underwent general anesthesia with LMA insertion by using classic Macintosh video layngoscopy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

McGRATH laryngoscopy

Patients who underwent general anesthesia with LMA insertion by using McGRATH video layngoscopy

Intervention Type DEVICE

Macintosh laryngoscopy

Patients who underwent general anesthesia with LMA insertion by using classic Macintosh video layngoscopy

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Group G Group I

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients underwent surgery with general anesthesia by LMA insertion in Sanglah General Hospital
* Agreed to be included in the study by signing informed consent
* American Society of Anesthesiologist physical status 1-2

Exclusion Criteria

* Patients unfit for LMA insertion
* Patients with suspected airway management difficulty
* Pregnancy
* Morbid obese
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Udayana University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christopher Ryalino

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sanglah General Hospital

Denpasar, Bali, Indonesia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Indonesia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1320/UN14.2.2.VII.14/LT/2020

Identifier Type: OTHER

Identifier Source: secondary_id

UNUD-CTR-FK270720-003

Identifier Type: -

Identifier Source: org_study_id